Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000499907 | SCV000593240 | uncertain significance | not specified | 2017-01-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000499907 | SCV000724441 | likely benign | not specified | 2017-11-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001516813 | SCV001725164 | benign | Spastic paraplegia | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002524151 | SCV003655898 | likely benign | Inborn genetic diseases | 2021-12-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003392327 | SCV004130479 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | AP4E1: BP4, BS1 |
Prevention |
RCV003932814 | SCV004747900 | likely benign | AP4E1-related disorder | 2023-03-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |